Glenview Capital Is Buying These Stocks in Third Quarter

Wall St. Watchdog reveals information regarding significant increase in shares for Glenview Capital Management’s holdings on the quarter ending September 30th, 2011. The firm is bullish on these stocks:

  • Sealed Air Corporation (NYSE:SEE): On 06/30/2011, Glenview Capital Management reported holding 0 shares. On 09/30/2011, Glenview Capital Management reported holding 4,318,800 shares. The net increase in shares for this position is 4,318,800. About Company: Sealed Air Corporation manufactures a wide range of packaging and performance-based materials and equipment systems. The Company’s products serve an array of food, industrial, medical, and consumer applications.
  • Agilent Technologies Inc. (NYSE:A): On 06/30/2011, Glenview Capital Management reported holding 0 shares. On 09/30/2011, Glenview Capital Management reported holding 900,000 shares. The net increase in shares for this position is 900,000. About Company: Agilent Technologies, Inc. provides core bio-analytical and electronic measurement solutions to the communications, electronics, life sciences and chemical analysis industries. The Company’s operations include electronic measurement, bio-analytical measurement, semiconductor and board testing.
  • Davita Inc. (NYSE:DVA): On 06/30/2011, Glenview Capital Management reported holding 0 shares. On 09/30/2011, Glenview Capital Management reported holding 223,316 shares. The net increase in shares for this position is 223,316. About Company: DaVita, Inc. provides dialysis services in the United States for patients suffering from chronic kidney failure. The Company treats patients through a network of owned and managed dialysis facilities in the continental United States.
  • Pharmaceutical Product Development Inc. (NASDAQ:PPDI): On 06/30/2011, Glenview Capital Management reported holding 0 shares. On 09/30/2011, Glenview Capital Management reported holding 504,406 shares. The net increase in shares for this position is 504,406. About Company: Pharmaceutical Product Development, Inc. (NYSE:PPD) offers drug discovery and development services to pharmaceutical, biotechnology, and medical device companies. The Company conducts pre-clinical programs and phase I to phase IV clinical trials. For approved drugs, PPD offers product launch services, and patient compliance and medical communications programs.
  • Laboratory Corp. Of America Holdings (NYSE:LH): On 06/30/2011, Glenview Capital Management reported holding 0 shares. On 09/30/2011, Glenview Capital Management reported holding 768,200 shares. The net increase in shares for this position is 768,200. About Company: Laboratory Corporation of America Holdings is a clinical laboratory organization. The Company offers a wide range of clinical laboratory tests which are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. Laboratory Corporation operates a network of laboratories and service sites which serve clients across the United States.

(Note: Data regarding Glenview Capital Management’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>